Search Prime Grants

U54CA224070

Cooperative Agreement

Overview

Grant Description
Rational approaches to melanoma therapy
Awardee
The Wistar Institute Of Anatomy And Biology
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Pennsylvania United States
Geographic Scope
State-Wide
Related Opportunity
Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) (RFA-CA-22-012)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/19 to 08/31/28 and the total obligations have increased 249% from $2,885,586 to $10,070,023.
The Wistar Institute Of Anatomy And Biology was awarded Rational approaches to melanoma therapy Cooperative Agreement U54CA224070 worth $10,070,023 from National Cancer Institute in September 2017 with work to be completed primarily in Pennsylvania United States. The grant has a duration of 11 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Cooperative Agreement was awarded through grant opportunity Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 4/25/25

Period of Performance
9/30/17
Start Date
8/31/28
End Date
72.0% Complete

Funding Split
$10.1M
Federal Obligation
$0.0
Non-Federal Obligation
$10.1M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA224070

Subgrant Awards

Disclosed subgrants for U54CA224070

Transaction History

Modifications to U54CA224070

Additional Detail

Award ID FAIN
U54CA224070
SAI Number
U54CA224070-31935967
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
DW1XZMGNFBL4
Awardee CAGE
8D701
Performance District
PA-90
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $11,810,424 100%
Modified: 4/25/25